A Phase I, Open-Label, 3-way Crossover, Pharmacokinetic and Drug-Drug Interaction Study of ceftazidime avibactam (CAZ-AVI) and Metronidazole when Administered Alone and in Combination in Healthy Subjects
The purpose of the study is to assess whether there is any pharmacokinetic interactions between CAZ-AVI and metronidazole.